RxDoctor Payments DataLook up a doctor →

Craig Wiener, MD

Obstetrics & Gynecology · Paramus, NJNPI 1801886148

Payments from drug & device makers

$12,605in general payments, 2019–2025

Across 582 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Minerva Surgical, Inc$2K
  • AbbVie$1K
  • Momentis Surgical Inc.$968
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$768
  • Celularity Inc.$600
  • Novo Nordisk$530
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Minerva Surgical, Inc3$1,605
AbbVie(2 entities)128$1,415
Momentis Surgical Inc.3$968
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC54$768
Celularity Inc.2$600
Novo Nordisk35$530
Pfizer31$522
Astellas Pharma US Inc21$522
Asensus Surgical, Inc.7$473
Millicent US Inc26$405
Mayne Pharma Commercial LLC25$365
Hologic Sales And Service, LLC7$351
Exeltis, USA Inc.21$310
Therapeuticsmd, Inc.16$224
Sumitomo Pharma America, Inc.13$221
Radius Health, Inc.12$183
Sage Therapeutics, LLC10$182
Teva Pharmaceuticals USA, Inc.12$176
Takeda Pharmaceuticals U.S.A., Inc.12$175
Medtronic3$168
Baxter Healthcare1$144
Amgen9$140
Exact Sciences6$135
Evofem Biosciences, Inc.8$121
IBSA Pharma Inc.8$120
Currax Pharmaceuticals LLC8$119
Agile Therapeutics, Inc.8$117
Lilly USA, LLC7$113
Integra Lifesciences Corporation2$90
Merz North America, Inc.1$80
Myovant Sciences Inc.5$71
Vivus LLC5$70
Lundbeck LLC4$70
Avion Pharmaceuticals5$65
Bayer3$60
Urovant Sciences Inc4$58
Mission Pharmacal Company4$55
Ironwood Pharmaceuticals, Inc4$54
Vertical Pharmaceuticals, LLC4$54
Duchesnay USA Incorporated4$53
Convatec Inc.2$44
Avanos Medical2$44
Mimedx Group, Inc.1$44
Dysis Medical, Inc.2$43
Mycovia Pharmaceuticals, Inc.2$42
Axonics, Inc.2$41
Supernus Pharmaceuticals, Inc.2$34
Samsung HME America, Inc.1$30
Nalpropion Pharmaceuticals LLC2$29
QOL Medical, LLC2$29
Kerecis Limited1$28
Lupin Inc.2$28
Channel Medsystems, Inc.2$27
Smith+Nephew1$21
Aspira Women's Health Inc1$18
Optumhealth Care Solutions, LLC1$18
BD1$17
Ascend Therapeutics US, LLC1$15
Shire North American Group Inc1$14
Vanda Pharmaceuticals Inc.1$14

How this compares

$12,605 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$46,427
Medicare patients
96
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Paramus

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →